Natixis Advisors LLC Sells 80,656 Shares of Colgate-Palmolive (NYSE:CL)

Natixis Advisors LLC lowered its stake in Colgate-Palmolive (NYSE:CL - Free Report) by 20.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 306,025 shares of the company's stock after selling 80,656 shares during the period. Natixis Advisors LLC's holdings in Colgate-Palmolive were worth $27,821,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Commonwealth Financial Services LLC boosted its position in shares of Colgate-Palmolive by 4.5% during the fourth quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company's stock worth $247,000 after buying an additional 118 shares during the period. D Orazio & Associates Inc. boosted its position in Colgate-Palmolive by 4.2% during the 4th quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company's stock worth $271,000 after acquiring an additional 120 shares during the last quarter. Lantz Financial LLC grew its stake in shares of Colgate-Palmolive by 0.6% during the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company's stock worth $1,831,000 after acquiring an additional 122 shares in the last quarter. Horizon Kinetics Asset Management LLC increased its stake in Colgate-Palmolive by 4.2% in the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company's stock valued at $322,000 after buying an additional 124 shares during the last quarter. Finally, Pine Haven Investment Counsel Inc increased its position in shares of Colgate-Palmolive by 1.0% in the fourth quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company's stock valued at $1,182,000 after acquiring an additional 130 shares during the last quarter. Institutional investors own 80.41% of the company's stock.

Remove Ads

Colgate-Palmolive Stock Performance

Shares of CL stock traded up $0.02 on Friday, hitting $90.30. The company's stock had a trading volume of 8,950,402 shares, compared to its average volume of 4,222,165. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The company has a market capitalization of $73.28 billion, a PE ratio of 25.65, a PEG ratio of 4.20 and a beta of 0.40. The stock's 50 day moving average is $89.25 and its 200-day moving average is $94.38. The company has a debt-to-equity ratio of 13.40, a quick ratio of 0.58 and a current ratio of 0.92.

Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same quarter last year, the firm posted $0.87 EPS. Equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive announced that its board has initiated a stock repurchase program on Thursday, March 20th that authorizes the company to buyback $5.00 billion in outstanding shares. This buyback authorization authorizes the company to repurchase up to 6.8% of its shares through open market purchases. Shares buyback programs are generally an indication that the company's board believes its stock is undervalued.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 17th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Thursday, April 17th. This is a boost from Colgate-Palmolive's previous quarterly dividend of $0.50. This represents a $2.08 annualized dividend and a yield of 2.30%. Colgate-Palmolive's payout ratio is currently 56.82%.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the company. StockNews.com lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Friday, March 14th. TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a "buy" rating on the stock in a report on Wednesday, January 8th. Stifel Nicolaus cut their price target on shares of Colgate-Palmolive from $95.00 to $93.00 and set a "hold" rating for the company in a research note on Monday, February 3rd. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an "overweight" rating on the stock in a research note on Monday, January 6th. Finally, Barclays cut their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an "equal weight" rating for the company in a research note on Friday, January 17th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has a consensus rating of "Hold" and a consensus target price of $101.72.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.